メタ情報
| meta description平均長 | 152.78 |
|---|
| OGPありページ数 | 87 |
|---|
| Twitterカードありページ数 | 87 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 640 |
|---|
| ページあたり内部リンク平均 | 54.34 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| Drug | 1 |
| therapy | 0.811191 |
| cancer | 0.639034 |
| vaccines | 0.62082 |
| KRAS | 0.572726 |
| Type | 0.546499 |
| surgical | 0.499258 |
| ACTR | 0.485529 |
| cells | 0.430584 |
| CRP | 0.411888 |
| inhibitors | 0.411888 |
| cell | 0.400403 |
| liver | 0.376254 |
| IPV | 0.342726 |
| diseases | 0.335865 |
| TTK | 0.329751 |
| Inc | 0.327823 |
| protein | 0.321306 |
| Vinci | 0.312396 |
| pressure | 0.299885 |
| system | 0.299312 |
| plasma | 0.295041 |
| generative | 0.285605 |
| health | 0.278465 |
| mental | 0.277685 |
| vaccine | 0.274592 |
| artificial | 0.272784 |
| therapies | 0.270397 |
| disease | 0.268692 |
| patient | 0.267915 |
| treatment | 0.267066 |
| environmental | 0.265595 |
| development | 0.264228 |
| data | 0.264185 |
| immune | 0.264185 |
| stem | 0.26211 |
| air | 0.26033 |
| gene | 0.253972 |
| production | 0.252952 |
| medical | 0.245701 |
| access | 0.245165 |
| potential | 0.244753 |
| embryo | 0.242975 |
| baculovirus | 0.242975 |
| chatbots | 0.242975 |
| adjuvants | 0.242975 |
| scintillation | 0.242975 |
| expression | 0.242764 |
| individuals | 0.241822 |
| increasing | 0.24115 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Portfolio | SWOT | 6.523176 | 2368 |
| Million | USD | 6.498571 | 1920 |
| Size | USD | 6.28532 | 1920 |
| Historical | Introduction | 6.076017 | 960 |
| Portfolio | Product | 5.914073 | 1908 |
| Asia | Pacific | 5.892988 | 730 |
| Primary | Sources | 5.475018 | 360 |
| Company | Overview | 5.365591 | 2875 |
| forecast | period | 5.31055 | 412 |
| Key | Players | 5.288864 | 940 |
| Drug | Type | 5.192053 | 476 |
| Overview | Strategic | 5.140512 | 2960 |
| Framework | Regulatory | 5.10539 | 372 |
| Make | Partners | 5.085724 | 200 |
| Buyer | Power | 5.077775 | 225 |
| Financial | SWOT | 5.065288 | 1776 |
| Published | Report | 5.048384 | 192 |
| America | North | 5.02813 | 664 |
| Data | Secondary | 4.986054 | 405 |
| Players | Regional | 4.959076 | 564 |
| Million | Size | 4.940399 | 1440 |
| Forecast | Million | 4.845994 | 960 |
| Code | Report | 4.834078 | 192 |
| Figures | Tables | 4.834078 | 192 |
| Figures | Pages | 4.834078 | 192 |
| total | valuation | 4.834078 | 192 |
| Mapping | Prospect | 4.834078 | 192 |
| Chain | Value | 4.834078 | 192 |
| Compliances | Standards | 4.834078 | 192 |
| Brazil | Venezuela | 4.834078 | 192 |
| Argentina | Venezuela | 4.834078 | 192 |
| France | Germany | 4.834078 | 192 |
| Russia | Spain | 4.834078 | 192 |
| Poland | Russia | 4.834078 | 192 |
| China | Japan | 4.834078 | 192 |
| ASEAN | Zealand | 4.834078 | 192 |
| France | Italy | 4.814275 | 192 |
| Italy | Spain | 4.814275 | 192 |
| Empowers | Its | 4.811326 | 200 |
| Its | Partners | 4.811326 | 200 |
| Financial | Strategic | 4.808813 | 1776 |
| GCC | Israel | 4.798468 | 184 |
| Canada | Mexico | 4.794872 | 192 |
| China | India | 4.794872 | 192 |
| Australia | India | 4.794872 | 192 |
| Scope | Years | 4.780041 | 180 |
| Considered | Years | 4.780041 | 180 |
| Covered | Currency | 4.780041 | 180 |
| Currency | Limitations | 4.780041 | 180 |
| Limitations | Stakeholders | 4.780041 | 180 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録